Astrocyte function is an important contributor to cellular viability during brain hypoxia and ischemia. Levels of the hypoxia-inducible transcription factors (HIFs) HIF-1 and HIF-2 are increased in hypoxic conditions and impact the neuroprotective properties of astrocytes. For example, HIF-2 induces levels of erythropoietin (EPO), a neuroprotectant, by astrocytes. In contrast, HIF-1 activity in astrocytes diminishes the viability of neurons in cocultures during hypoxia. Thus, HIF-1 and HIF-2 may have opposing effects on astrocytes. In this study, we explore the balance of HIF-1 and HIF-2 signaling in astrocytes during chronic (1-7 d) hypoxia while altering the degree of hypoxia and glucose availability. In addition, we investigate the effects of these conditions on neuron apoptosis. During exposure to chronic moderate hypoxia (2% O 2 ) and plentiful glucose (10 mM), HIF-2 and EPO abundance increases from d 1 to 7. Similarly, pretreatment with moderate hypoxia markedly increases the abundance of HIF-2 and EPO when astrocytes are subsequently exposed to severe hypoxia (0.5% O 2 ; 24 h) in 10 mM glucose, which inhibits neuron apoptosis in coculture. Although HIF-1 targets the expression increase during the 7 d in chronic moderate hypoxia (2% O 2 ) and limited glucose (2 mM), further exposure to severe hypoxia (0.5% O 2 ; 24 h) induces a decrease of most HIF-1 targets in astrocytes. Notably, in astrocyte exposure to 2% O 2 prior to 0.5% O 2 , the expression of iNOS, an HIF-1-regulated protein, keeps increasing when glucose is limited, whereas EPO and VEGF abundance is suppressed, inducing increased apoptosis of neurons in coculture under limited glucose (2 mM). Thus, both hypoxic severity and glucose abundance regulate the balance of HIF-1 and HIF-2 activity in astrocytes, leading to diverse effects on neurons. These results could have important implications on the adaptive or pathologic role of astrocytes during chronic hypoxia and ischemia.-Guo, M., Ma, X., Feng, Y., Han, S., Dong, Q., Cui, M., Zhao, Y. In chronic hypoxia, glucose availability and hypoxic severity dictate the balance between HIF-1 and HIF-2 in astrocytes. FASEB J. 33, 11123-11136 (2019). www.fasebj.org KEY WORDS: neuron apoptosis • hypoxic preconditioning • EPO • VEGF • iNOS Astrocytes, the most abundant glial cells, are active partners of neurons in their response to hypoxia by expressing various neurotransmitter receptors and transporters and releasing regulating factors that alter neuronal physiology and survival. The role of astrocytes on neuronal survival ABBREVIATIONS: CSF, cerebrospinal fluid; EPO, erythropoietin; Glut, glucose transporter; HIF, hypoxia-inducible transcription factor; HK2, hexokinase 2; LDH, lactate dehydrogenase; MCT4, monocarboxylase transporter 4; Nip-3, BCL2/adenovirus E1B 19-kDa interacting protein 3 1 These authors contributed equally to this work.
during hypoxia is complex, involving both adaptive and pathologic functions. Additionally, secretion of neurotrophins by astrocytes likely provides critical support for neighboring cells during hypoxia (1) (2) (3) . It has been reported that astrocytes mediate the protective effects of ischemic preconditioning (4) . In addition, hypoxiainducible pathways are activated in astrocytes during chronic white matter ischemia (leukoaraiosis), perhaps as a results of hypoperfusion of white matter (5, 6) . Similar findings have been observed in oxygen-glucose deprivation models and in an ischemia mouse model (7, 8) . Chronic or intermittent hypoxia accompanies multiple disease states such as pulmonary disease, congestive heart failure, and sleep apnea. However, the contribution of astrocytes to neurons during chronic hypoxia remains unknown.
Beyond disease states, hypoxia also shapes normal physiology and brain development (9, 10) . It has been documented that the oxygen tension in the brain is ;2% in the brainstem, whereas it is closer to 5% O 2 (30 mmHg) in the cortex (11) (12) (13) . These physiologic values are well below the 21% O 2 in room air. Despite the lower physiologic oxygen tensions within the brain, experiments that examine hypoxic signaling in astrocytes and neurons inevitably culture cells at 21% O 2 prior to only brief exposure to hypoxia. Interestingly, when neurons are cultured in conditions of chronic hypoxia (1-2 wk), neurons maintain their health longer (11) (12) (13) . The data imply that culturing cells in normoxia (21% O 2 ) may have deleterious effects and impede neuroprotective signaling induced by a physiologic hypoxic atmosphere. In addition to this physiologic hypoxia, vascular disease may limit oxygen and glucose availability. Thus, to better understand how hypoxia impacts astrocyte function, experimental paradigms need to be employed which better model chronic hypoxia. Furthermore, the potential effects of reduced glucose abundance that may accompany vascular disease also require further investigation.
The hypoxia-inducible transcription factors (HIFs) HIF-1a and HIF-2a coordinate the transcriptional response of astrocytes to hypoxia (14) . Astrocytes are a primary source of erythropoietin (EPO) in the brain (15) , and EPO is induced primarily through the actions of HIF-2 within astrocytes (15) . EPO abundance is markedly induced during hypoxia and functions as a neuroprotectant for surrounding cell types (7, 16, 17) . It has also been found that exogenous administration of EPO to rodents during acute stroke reduces stroke volume (18, 19) , improves recovery after focal stroke or exposure to hypoxia-ischemia (20, 21) , and improves plasticity and recovery when administered after a stroke (22) . EPO also contributes significantly to the neuroprotection mediated by hypoxia preconditioning (23, 24) . Thus, it is assumed that increased HIF-2 activity and EPO levels in astrocytes are neuroprotective in hypoxia-ischemia. In contrast, it was reported that hypoxia-induced HIF-1 signaling in astrocytes augments neuronal death in cocultures of astrocytes and neurons, and selective loss of HIF-1 function in astrocytes markedly protects neurons from hypoxic-induced neuronal death (25) . Therefore, the activities of HIF-1 and HIF-2 in astrocytes may have opposing effects and the relative balance of these transcription factors could influence the neuroprotective functioning of astrocytes. Further research has observed an increase of HIF-1a in astrocytes and indicated that this provides a contribution to ischemic tolerance in a transient middle cerebral artery occlusion model (8) . Although it is clear that different levels of glucose and hypoxia exist between various experimental models, the reason for these apparently different functions remains unknown.
To better delineate the hypoxia signaling cascades that control the balance of HIF-1 and HIF-2 signaling in astrocytes, we tested HIF-1 and HIF-2 signaling under various oxygen tensions during chronic hypoxia and with different concentrations of glucose. We found that astrocytes exposed to moderate hypoxia (2% O 2 ) and abundant glucose (10 mM) for 7 d increased HIF-2 and EPO expression, whereas HIF-1 targets remained largely unchanged, indicating a neuroprotective role. However, the positive effect of astrocytes by exposure to chronic 2% O 2 was completely lost when glucose concentrations were reduced to 2 mM, which was mirrored by reductions in HIF-2 and EPO abundance. Interestingly, in contrast to HIF-2, HIF-1 targets had the opposite pattern in chronic 2% O 2 when glucose levels were altered. That is, HIF-1 targets increased in chronic 2% O 2 when glucose was diminished to 2 mM glucose. Thus, in chronic moderate hypoxia (2% O 2 ), the balance of HIF-1 and HIF-2 signaling was dependent on glucose availability, with HIF-2 signaling being prevalent when glucose was abundant and HIF-1 signaling being prevalent when glucose was limited. These observations describe, for the first time, the complex interactions of hypoxia and glucose abundance on the balance of HIF-1 and HIF-2 signaling. Deciphering the mechanisms contributing to this balance could have important implications for enhancement of the neuroprotective actions of astrocytes during hypoxia-ischemia, hypoperfusion, and recovery from stroke.
MATERIALS AND METHODS

Transgenic mice and methodology for creating loss of HIF-1 or HIF-2 function
Multiple lines of transgenic mice were used in these studies, the creation of which is detailed elsewhere (25) . Transgenic mice included HIF-1a F/F (26), HIF-2a F/F (27) , and tamoxifen-regulated cre (EsrCre) mice (28) . HIF-1a F/F mice were obtained from Dr. Randall Johnson, HIF-2a F/F were developed by Dr. M. Celeste Simon, and EsrCre mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in the experimental animal center at a temperature of 21 6 1°C with 12 h light/dark cycles and given ad libitum access to food and water. To achieve loss of HIF-1 or HIF-2 in astrocyte cultures, HIF-1a F/F or HIF-2a F/F mice were bred with EsrCre mice to achieve bigenic mice. Loss of HIF-1 or HIF-2 function was then achieved by treating the cultures with tamoxifen (0.1-1.0 mM) for 48 h. The study was approved by the Ethics Committee of Fudan University (20150572A259). This manuscript was written in accordance with the Animal Research: Reporting In Vivo Experiments guideline.
Astrocyte culture preparation and exposure to hypoxia All methods were approved by the university committee devoted to the ethical use of animals in research. Primary astrocyte cultures were prepared from postnatal day (P)0 mice as previously detailed by Rempe et al. (29) . After astrocyte cultures reached confluence, HEPES and cytarabine (AraC) were added to maintain pH and prohibit microglial proliferation, respectively. All cultures were confluent at the time of hypoxia exposure initiation. Hypoxia exposure was accomplished by placing cultures into a hypoxia glove box (Coy Laboratory Products Inc., Grass Lake, MI, USA) and replacing oxygen with nitrogen to achieve the desired oxygen tension while maintaining the CO 2 at 5%. Once cultures were placed into hypoxic conditions, all manipulations of the cultures were done without interrupting the hypoxic atmosphere. All media used to feed the cultures were pre-equilibrated in the hypoxia chamber prior to use. Several experimental paradigms were employed. In some cases, cultures were maintained in 21% (normoxia) or 2% (moderate hypoxia) O 2 for 1, 3, or 7 d before collection of RNA, protein lysates, and medium (for the measurement of EPO and VEGF secreted in medium). In other cases, cultures were exposed to 0.5% O 2 for 24 h after the cultures had been maintained in 21 or 2% O 2 for 7 d (Fig. 1A) .
Primary neuron culture
Primary cortical neuron cultures were prepared from embryonic d 16 to 18 of C57BL/6 mouse brains. Briefly, the cortex was dissected away from the brainstem, and the meninges were removed. The tissue was digested in trypsin-EDTA (0.1%) for 20 min and dispersed in neurobasal medium containing 2% B27, 2 mM L-glutamine, and penicillin-streptomycin (21103049, 17504044, and 35050061; Thermo Fisher Scientific, Waltham, MA, USA). The cells were plated on 15-mm poly-L-lysine-coated glass coverslips in 6-well plates at a density of 3-10 3 10 5 cells/ml and maintained at 37°C with 5% CO 2 . The cultured neurons were used for studies on in vitro d 8-10.
Astrocyte-neuron coculture
Transwell inserts (Corning, Corning, NY, USA) were used for the study of astrocytes and neuron coculture. Primary neurons grown on coverslips were put to 24-mm inserts on in vitro d 8-10. Astrocytes were seeded into a 6-well culture plate. After 7 d of stimulation by the different hypoxia protocols, the inserts were placed into the wells of the 6-well plate, where neurons were cultured for 24 h with astrocyte culture medium under 21 or 0.5% O 2 . In this Transwell model, neurons and astrocytes were separable, and the effect of soluble factors released from astrocytes on neurons could be studied separately. After 24 h of coculture, neurons were collected for TUNEL assay.
RNA purification and synthesis of cDNA RNA purification and cDNA synthesis were performed as previously described in refs. 29 and 30. Briefly, RNA was isolated using RNAeasy Columns (Qiagen, Hilden, Germany) as per the manufacturer's recommendations. SuperScript III (Thermo Fisher Scientific) was used as per the manufacturer's recommendations to synthesize cDNA. As a template for first-strand synthesis, 400-500 ng of total RNA was used.
Real-time PCR using TaqMan
Quantitative PCR was performed as previously described in refs. 29 and 30. The nucleotide sequences of the primers and probes are listed in prior publications from this group (29) . Each PCR experiment was performed with 3-4 replicate wells. An ABI Prism 7700 Sequence Detector Real-Time PCR Thermocycler (Thermo Fisher Scientific) was used for measuring concentrations of mRNA. Target abundance was normalized to b-actin as an internal control.
Isolation of protein lysates, Western blots, and ELISAs
Isolation of nuclear and cytoplasmic proteins was performed using a rapid method described by Andrews and Faller (31) and detailed by Rempe et al. (29) . Western blots were undertaken on nuclear-enriched protein lysates and diluted into buffer containing SDS and b-mercaptoethanol to ensure denaturation, and electrophoresis was performed using polyacrylamide gels. Protein was transferred to PVDF membranes (MilliporeSigma, Burlington, MA, USA). After exposure to blocking buffer, membranes were placed in blocking buffer containing anti-HIF-1a antibody (1/500 Figure 1 . Pretreatment of astrocytes in chronic 2% O 2 prior to severe 0.5% O 2 has opposite effects on cocultured neurons under 10 and 2 mM glucose, which involves HIF-2 and HIF-1.
A) The experimental paradigm showing the 3 experimental conditions. We had 3 groups in our study: 1 set of cultures was maintained at 21% O 2 [normoxia (Norm)] for the entire experiment, a second set of cultures was maintained at 21% O 2 for 7 d and was then stepped to 0.5% O 2 for 24 h (Norm to 0.5% group), and a third group of cultures was maintained at 2% O 2 for 7 d and then stepped to 0.5% O 2 for 24 h (2-0.5% group). A total of 3 experiments were designed and performed under 10 or 2 mM glucose. In experiment 1, astrocytes were cultured in 21% O 2 or 2% O 2 for 7 d, then cocultured with neurons in 21% O 2 or 0.5% O 2 for 24 h. In experiment 2, astrocytes were cultured in 21% O 2 or 2% O 2 for 7 d, followed by 21% O 2 or 0.5% O 2 for 24 h. In experiment 3, astrocytes were cultured in 21% O 2 or 2% O 2 for 1, 3, and 7 d. B, C ) Detection of apoptosis in neurons by TUNEL and counterstaining with DAPI for the visualization of nuclei. TUNEL: green; DAPI: red; Merge: yellow. Scale bar, 20 mm. The percentage of TUNEL-reactive cells was represented graphically as the mean 6 SEM (n = 4 independent experiments; 2-way ANOVA followed by Tukey's multiple comparison test). *P , 0.05 vs. Norm, : P , 0.05 vs. Norm to 0.5%, # P , 0.05 vs. 2-0.5%. dilution; Novus Biologicals, Centennial, CO, USA), anti-HIF-2a antibody (1/500 dilution; Novus Biologicals), anti-ERK antibody (1/3000; Cell Signaling Technology, Danvers, MA, USA), antiphosphorylated ERK antibody (1/1000; Cell Signaling Technology), anti-iNOS antibody (1/500; Novus Biologicals), or an antibody specific for b-actin (32) . ELISAs were performed to measure EPO and VEGF per the manufacturer's recommendations (R&D Systems, Minneapolis, MN, USA) after concentrating the samples by a speed vacuum to ;20% of their original volume. Each experiment was performed with 3 replicate wells.
TUNEL assay and lactate dehydrogenase assay
The apoptotic neurons were detected using an ApopTag In Situ TUNEL Kit (InterGen, Edinburgh, United Kingdom) following the manufacturer's instructions. Cell nuclei were counterstained with DAPI. Using high-power field (4003 magnification) fluorescent microscopy, the number of apoptotic cells characterized by the TUNEL-stained nuclei was counted in 10 randomly selected fields. The percentage of apoptotic cells per field was calculated for further statistical analysis.
Cytotoxicity of astrocytes was assessed in supernatants using a lactate dehydrogenase (LDH) cytotoxicity detection kit (Takara Bio, Kusatsu, Japan) according to the manufacturer's protocol. LDH activity was determined by measuring absorbance at 490 nm.
Statistical analysis
Prism 7 software (GraphPad Software, La Jolla, CA, USA) was used in order to perform statistical analysis of experimental results. All values are given as means 6 SEM. Each experiment was conducted independently $3 times. Comparison between 2 groups was achieved using the unpaired Student's t test. The 1-or 2-way ANOVA followed by Tukey's multiple comparison test was used for multiple comparisons. Values of P , 0.05 were considered to be statistically significant.
RESULTS
After hypoxia exposure, loss of HIF-1 or HIF-2 function in astrocytes play opposite roles on neuron apoptosis in the presence of 10mM glucose and 2mM glucose.
The principal goal of this study is to evaluate the impact of astrocytes on hypoxia-induced neuronal death under plentiful (10 mM) and limited glucose (2 mM). Given that the physiologic oxygen tension of the brain is 1-5%, it is of interest to determine if chronic exposure of astrocyte cultures to physiologic hypoxia (2%) alters their subsequent response to severe hypoxia (0.5% O 2 ), as might be experienced during brain ischemia. Typically, culture experiments are performed in an abundance of glucose (10-25 mM). However, glucose concentration in cerebrospinal fluid (CSF) is closer to 3-4 mM, and some disease states are accompanied by diminished glucose availability. Thus, we were also interested in the effect of a modest reduction of glucose (2 mM) on astrocyte-neuron cocultures. First, we examined apoptosis of neurons in these cocultures after exposure to 3 hypoxia protocols ( Fig. 1A) . Compared with normoxia, exposure of astrocytes to 2% O 2 for 7 d decreased apoptosis of neurons in coculture following hypoxia in 0.5% O 2 when cultured in the presence of 10 mM glucose. However, the same regimen of hypoxia treatment increased neuronal apoptosis under 2 mM glucose conditions ( Fig. 1B, C) . Together, this indicates that astrocytes respond differently when subjected to chronic moderate hypoxia in the presence of different glucose levels. Among effectors responsible for cellular response to hypoxia, HIFs, including HIF-1 and HIF -2, are considered master molecules that initiate a multitude of downstream signaling cascades. Thus, HIF-1 2/2 and HIF-2 2/2 astrocytes were adopted to evaluate the role of HIFs in regulating astrocyte response under the above condition. Interestingly, loss of HIF-1 function in astrocytes inhibited neuron apoptosis under 2 mM glucose rather than 10 mM glucose, whereas loss of HIF-2 function in astrocytes caused more pronounced levels of apoptosis in the presence of 10 mM glucose ( Fig. 1B, C) , suggesting that HIF-1 exerted a harmful role under 2 mM glucose and HIF-2 exerted a protective role under 10 mM glucose when pretreated with 2% O 2 hypoxia followed by 0.5% O 2 .
The induction of HIF-2 protein by 0.5% O 2 is maintained, whereas HIF-1 protein abundance is diminished by pretreatment with chronic 2% O 2 under 10 mM glucose
The results above demonstrate that HIF-1 and HIF-2 in astrocytes is involved in the regulation of neuronal apoptosis. First, we explored the regular pattern of HIFs in astrocytes cultured in the presence of 10 mM glucose. Using Western blots, we examined HIF-2 and HIF-1 protein abundance. In cultures maintained in normoxia prior to exposure to severe hypoxia (0.5% O 2 ) for 24 h, a prominent hypoxia-induced HIF-2 band was observed, but pretreatment with 2% O 2 did not further increase HIF-2 protein abundance ( Fig. 2A, B) . We next examined HIF-1 protein abundance under these same conditions. Surprisingly, pretreatment with 2% O 2 reduced the HIF-1 protein abundance induced by exposure to 24 h of 0.5% O 2 (Fig. 2C , D). In addition, HIF-1 protein induction was not observed by Western blot in samples from the chronic exposure to 2% O 2 culture condition. As such, changes of HIF-1 protein abundance could not be evaluated in moderate chronic hypoxia.
Pretreatment with chronic moderate hypoxia (2% O 2 ; 7 d) prior to acute severe hypoxia (0.5% O 2 ; 24 h) dramatically increases expression of the HIF-2 target EPO, whereas HIF-1 targets remain either unchanged or decreased in astrocytes cultured in 10 mM glucose Next, we examined the targets of HIF-1 and HIF-2 after astrocyte cultures were exposed to 1 of 3 experimental protocols. Prior work by others (7, 15) demonstrated that induction of EPO is dependent on HIF-2 function during acute hypoxia. Interestingly, the abundance of EPO transcripts was increased by .2-fold in astrocyte cultures pretreated with chronic 2% O 2 prior to exposure to 0.5% O 2 (Fig. 3A) . Using HIF-2 2/2 astrocytes, we confirmed that the enhanced expression of EPO by cultures pretreated with chronic 2% O 2 was mediated by HIF-2 function. When treated with tamoxifen, HIF-2 transcript levels were reduced to ,5% of baseline levels in these cultures (Supplemental Fig. S1A ). Correspondingly, EPO transcripts of astrocytes in cultures were markedly reduced after exposure to severe hypoxia (Supplemental Fig. S1B, C) . Moreover, astrocytes pretreated with moderate chronic hypoxia did not further induce EPO expression when exposed to severe hypoxia when HIF-2 function was removed. Thus, EPO expression is mainly mediated by HIF-2. Despite the fact that HIF-2 protein abundance is unchanged by pretreatment of chronic exposure to 2% O 2 from d 3 to 7, the data suggest that the ability of HIF-2 to transactivate its targets is enhanced by exposure to chronic mild-moderate hypoxia, which is not dependent on increasing HIF-2 protein abundance.
In contrast, HIF-1 targets did not demonstrate this same enhanced activity with exposure to chronic 2% O 2 prior to exposure to severe hypoxia. Exposure to 0.5% O 2 significantly induced the transcription of VEGF, glucose transporter (Glut)1, hexokinase 2 (HK2), monocarboxylase transporter 4 (MCT4), and the proapoptotic B-cell lymphoma 2 family member Nip3 (BCL2/adenovirus E1B 19-kDa interacting protein 3). Yet, unlike EPO, pretreatment of the astrocyte cultures with 1 wk of 2% O 2 before Figure 2 . Protein abundance of HIF-1 and HIF-2 in astrocytes after exposure to different hypoxia conditions maintained in 10 mM glucose. A, B) HIF-2 protein was induced to similar levels by exposure to 0.5% O 2 whether or not it was pretreated in 2% O 2 (long arrow: HIF-2 band; arrowhead: nonspecific band). C, D) HIF-1 protein was induced by exposure to 0.5% O 2 but reduced to a lesser amount when the cultures were pretreated in 2% O 2 (long arrow: HIF-1 band; arrowhead: nonspecific band). Norm, normoxia. Data are shown as means 6 SEM (n = 8 independent experiments; 1-way ANOVA followed by Tukey's multiple comparison test). *P , 0.05 vs. Norm, # P , 0.05 vs. Norm to 0.5%. exposure to 0.5% O 2 did not enhance expression of these targets. In fact, following pretreatment with 2% O 2 , the abundance of HIF-1 protein induced by 0.5% O 2 is markedly reduced (Fig. 2C, D) even though its targets are only modestly changed ( Fig. 3B-F ), suggesting the remaining fraction of HIF-1 effectively transactivates its targets. Similar to HIF-2, we examined whether these HIF-1 targets are dependent on HIF-1 function when astrocytes are exposed to chronic 2% O 2 . Conditional loss of HIF-1 function was achieved by pretreatment of HIF-1a F/F ::EsrCre cultures with tamoxifen, which reduced HIF-1 transcript to ,2% of baseline levels (Supplemental Fig. S2A ). Using this approach, we found that the hypoxic induction of HK2, Glut1, Nip3, and MCT4 by 0.5% O 2 was virtually completely dependent upon HIF-1 function, whether or not they were pretreated by chronic 2% O 2 (Supplemental Fig.  S2C-F) . The data suggest that HIF-1 target expression induced by severe hypoxia is either unaltered or only modestly reduced by pretreatment with chronic 2% O 2 (Fig. 3C-F) .
As for VEGF, exposure to 0.5% O 2 increased VEGF transcript abundance, which was not further increased by pretreatment of astrocytes with 2% O 2 , in contrast to EPO ( Fig. 3B and Supplemental Fig. S1D ). Despite that there was no further increase in transcription level, VEGF protein levels were further increased by 2% pretreatment (Supplemental Fig. S1E ). The transcription of VEGF was only partially dependent on HIF-1 function ( Supplemental Fig. S2B) , and a much more modest reduction in VEGF transcript and protein abundance was observed with loss of HIF-2 function (Supplemental Fig. S1D, E) , suggesting VEGF abundance is mediated by both HIF-1 and HIF-2, in agreement with prior work (7, 29) . Taken together, the data suggest that pretreatment in chronic moderate hypoxia differentially regulates HIF-1 vs. HIF-2.
HIF-2 rather than HIF-1 is the primary regulation factor during chronic moderate hypoxia in astrocytes cultured under 10 mM glucose Because pretreatment of astrocyte cultures with chronic 2% O 2 prior to 0.5% O 2 protected neurons from apoptosis and markedly increased EPO abundance in the presence of 10 mM glucose, we wanted to know how and when this protective response by astrocytes occurred during the 7 d under 2% O 2 . We went on to examine the effects of chronic moderate to mild hypoxia (2% O 2 ) on HIF-1 and HIF-2. After 24 h of 2% O 2 , the HIF-1 targets Glut1, HK2, MCT4, and Nip3 were all increased above their values in normoxia (Supplemental Fig. S3 ). When maintained chronically in 2% O 2 , transcript abundance of these targets remained essentially unchanged from d 1 to 7 of hypoxia exposure (Supplemental Fig. S3 ). Despite HIF-1 targets being induced during 2% O 2 , HIF-1 protein induction could not be observed by Western blot.
HIF-2 and EPO transcripts were increased with chronic exposure to 2% O 2 , whereas loss of HIF-2 function markedly reduced EPO transcript and protein abundance in cultures maintained at 2% O 2 for 7 d (Fig.  4A, B) . During chronic exposure to moderate hypoxia, HIF-2 protein was induced by 2% O 2 , and its abundance remained constant between d 1 and 7 of exposure ( Fig.  4D, E) . Similarly, EPO transcript abundance showed an increasing trend in astrocyte cultures exposed chronically to 2% O 2 (Fig. 4F ). Here, VEGF showed a similar trend to EPO (Fig. 4C, G) . The data demonstrate that HIF-1 target (Glut1, HK2, MCT4, and Nip3) expression is initially induced and then maintained in mild to moderate chronic hypoxia, whereas EPO and VEGF transcript expression increases under these same conditions. Thus, similar to the findings above, the data support that HIF-1 and HIF-2 are differentially regulated in chronic hypoxia.
Reduced glucose abundance inhibits the ability of pretreatment with chronic 2% O 2 to enhance the induction of EPO by severe hypoxia in astrocytes An acute exposure of astrocyte cultures to 0.5% O 2 and 2 mM glucose induced EPO transcript levels by ;60-fold ( Fig. 5A) , which was almost identical to that induced in cultures maintained in 10 mM glucose (Fig. 3A) . However, pretreatment with chronic 2% O 2 did not further enhance EPO transcript expression when the cultures were maintained in 2 mM glucose ( Fig. 5A) . Thus, the ability of moderate chronic hypoxia to enhance transactivation of HIF-2 targets is dependent on glucose availability. In cultures maintained in 2 mM glucose, pretreatment with 2% O 2 significantly decreased the VEGF transcript abundance (Fig. 5B ) and reduced the induction of some HIF-1 targets (Glut1 and HK2) by ;50% of those maintained at 21% O 2 (Fig. 5C, D) . However, other HIF-1 targets were either unchanged (Nip3) or only somewhat increased (MCT4) by pretreatment with 2% O 2 (Fig. 5E, F) .
If the health of the astrocyte cultures were impaired when they are cultured in 2 mM glucose and chronic 2% O 2 , this could explain why enhanced EPO expression is not observed after pretreatment with 2% O 2 . However, no cell death was observed when evaluated by LDH ( Supplemental Fig. S4A ). In addition, as described above, the reduction of transcript abundance was not universal, and certain transcripts such as Nip3 and MCT4 were not diminished under these conditions. Because cells exposed to significant cellular stress over a period of time reduce protein translation, we measured the release of VEGF into the medium by these cells after being maintained in either 21 or 2% O 2 (2 or 10 mM glucose) for 1 wk. The concentration of VEGF in the medium induced by exposure to 2% O 2 was not reduced in cultures maintained in 2 mM glucose and 2% O 2 (Supplemental Fig. S4B ). In fact, VEGF protein was significantly increased in cells maintained in 2 mM vs. 10 mM glucose. Thus, the effects of reduced glucose on EPO abundance cannot be simply explained by reduced cell viability or health.
During chronic 2% O 2 , HIF-1 target expression in astrocytes is enhanced in 2 mM glucose
To explore how glucose availability influences the response of HIFs in astrocytes during chronic hypoxia, cultures were exposed to 2% O 2 and 2 mM glucose. Interestingly, a much different and divergent pattern of HIF-1 and HIF-2 target expression emerges. In 10 mM glucose, HIF-1 target transcript abundance remained unchanged from d 1 to 7 when cultures were exposed to chronic 2% O 2 ( Fig. 3 and Supplemental Fig. S3 ). In contrast, although HIF-1 transcript abundance remained unchanged (Fig. 6A) , the expression of most HIF-1 targets increased from d 1 to 7 of 2% O 2 exposure when cultures were in 2 mM glucose ( Fig. 6B-F) . In most cases, HIF-1 target transcript abundance was significantly increased in 2 mM glucose compared with 10 mM glucose. Removing HIF-1 function in astrocytes reduced transcript abundance of all the HIF-1 targets during acute and chronic hypoxia (Supplemental Fig. S5 ), with some (Nip3 and HK2) being largely eliminated and others (Glut1 and VEGF) partially reduced (Supplemental Fig. S5 ). This suggests that the increases in HK2, Glut1, and Nip3 transcripts are dependent on HIF-1.
During chronic 2% O 2 , levels of HIF-2 transcript, HIF-2 protein, and phosphorylation of ERK in astrocytes are diminished in 2 mM glucose culture conditions
We next explored the mechanisms by which glucose abundance contributes to differential HIF-2 response in astrocytes maintained in 2% O 2 under conditions of abundant (10 mM) or reduced (2 mM) glucose ( Fig. 7) . When glucose was abundant, HIF-2 transcript levels modestly increased from d 1 to 7 of exposure to 2% O 2 (Fig.  7A) . In contrast, HIF-2 transcript level was significantly reduced when cultures were maintained in 2% O 2 and 2 mM glucose (Fig. 7A ). EPO transcription trend was similar with HIF-2 ( Fig. 7B ). Instead of increasing, EPO transcript levels diminished from d 1 to 7 of exposure to 2% O 2 and 2 mM glucose (Fig. 7B ). EPO transcript expression was significantly lower at d 7 of hypoxia when maintained in 2 mM glucose compared with 10 mM glucose (Fig. 7B) . Western blots on astrocyte cultures showed that, similar to that shown above (Fig. 4D, E) , HIF-2 protein was maintained for 7 d in 10 mM glucose (Fig. 7C, D) . However, when cultures were maintained in 2 mM glucose, HIF-2 protein abundance was diminished after 7 d of hypoxia (Fig. 7C, D) . Some reports suggest that ERK signaling is enhanced by hyperglycemia (7, 29) , so we examined ERK phosphorylation during chronic hypoxia and its dependence on glucose availability. Similar to HIF-2 abundance, ERK phosphorylation was maintained in 10 mM glucose during chronic hypoxia but was reduced in cultures maintained in 2 mM glucose ( Fig. 7E, F) . Together, these data suggest that HIF-2 and EPO are down-regulated during chronic moderate hypoxia and 2 mM glucose.
EPO and VEGF protein levels are diminished and iNOS increases in astrocytes pretreated with 2% O 2 before severe hypoxia in 2 mM glucose culture conditions
We observed that, compared with normoxia to 0.5% O 2 , astrocytes from 2 to 0.5% O 2 increased neuronal apoptosis in coculture under 2 mM glucose ( Fig. 1B, C) . Furthermore, we found that VEGF and Glut1 transcript abundance was decreased in astrocytes pretreated with 2% O 2 prior to 0.5% O 2 in 2 mM glucose ( Fig. 5B, C) when compared with cells exposed to 0.5% O 2 directly, although their transcription levels were increased during the 7 d in 2% O 2 (Fig. 6B, C) . In addition, transcript abundance of HIF-2 and EPO were also declined during the 7 d in 2% O 2 , as mentioned above (Fig. 7A, B) . Was this increased neuronal apoptosis induced by the reduction of neuroprotective factors like EPO and VEGF from astrocytes? To confirm the EPO and VEGF protein levels in medium from astrocyte exposure to 2% O 2 followed by 0.5% O 2 , ELISA was performed. Results showed that EPO and VEGF protein levels changed inversely in 2 mM glucose and 10 mM glucose (Fig. 8A, B) . In contrast to 10 mM glucose, pretreatment with 2% O 2 prior to 0.5% O 2 decreased EPO and VEGF protein levels when compared with normoxia to 0.5% O 2 . Another explanation for increased neuronal apoptosis could be that harmful factors from astrocytes were increased. Considering that transcript abundance of many HIF-1 targets increased during the 7 d in 2% O 2 (Fig. 6B, C) , iNOS, another HIF-1regulated protein in astrocytes, may be involved in neuronal apoptosis through the induction of NO. Thus, we examined iNOS protein expression in astrocytes after different glucose and O 2 treatments. Compared with normoxia to 0.5% O 2 , pretreatment with 2% O 2 prior to 0.5% O 2 decreased iNOS expression in 10 mM glucose (Fig. 8C) , whereas in 2 mM glucose, iNOS levels were further elevated in 2% O 2 -pretreated astrocytes.
The responses of HIF-1 and HIF-2 differ during chronic hypoxia, which is dependent on glucose availability
This distinct pattern of transcript expression of HIF-1 and HIF-2 targets in 2% O 2 and 2 mM glucose (compared with 2% O 2 and 10 mM glucose) illustrates the complex interaction that the severity of hypoxia and glucose availability share in determining the relative activity of HIF-1 and HIF-2 in astrocytes, exerting different influences on neurons. A summary of the changes that occur in HIF-1 or HIF-2 target expression in astrocytes as a function of oxygen tension and glucose availability is illustrated in Fig. 9 .
DISCUSSION
In astrocytes, the relative balance of HIF-1 and HIF-2 function may have important implications for the ability of astrocytes to support neurons during hypoxia, ischemia, and hypoperfusion. The regulating patterns of HIF-1 and HIF-2 in astrocytes and how they impact neurons is beginning to attract more attention. In this study, we demonstrate that both severity of hypoxia during pretreatment and glucose availability alter the balance of HIF-1 and HIF-2 signaling during chronic hypoxia. First, pretreatment in 2% O 2 as opposed to 21% O 2 prior to severe hypoxia (0.5% O 2 ) increases HIF-2 and EPO expression in high glucose and plays a neuroprotective role but not when glucose is limited. Similarly, during chronic moderate hypoxia, the expression of HIF-2 and EPO increases over time when glucose concentrations are plentiful (10 mM) but decreases if glucose availability is limited (2 mM). In contrast, HIF-1 target expression in astrocytes remains unchanged from d 1 to 7 in chronic moderate hypoxia when glucose is plentiful but increases if glucose availability is limited. Further severe hypoxia (0.5% O 2 ) exposure following 7 d in 2% O 2 under 2 mM glucose decreases EPO and VEGF from astrocytes and increases iNOS, which has a harmful effect on neurons in coculture. Thus, HIF-1 and HIF-2 targets have the opposite response to chronic 2% O 2 when glucose is limited. Both the severity of hypoxia and glucose abundance alter the balance of HIF-1 and HIF-2 activity within astrocytes and subsequently influence the interaction between astrocytes and neurons.
Physiologic and pathologic roles of chronic hypoxia in the brain As discussed above, the normal oxygen tension of the brain is well below that encountered in room air. The oxygen tension is measured at 25-30 mmHg (;5-6% O 2 ) in the cortex and 6-16 mmHg (;1-2% O 2 ) in subcortical white matter and brain stem (11) (12) (13) . This physiologic hypoxia impacts multiple physiologic processes, including brain development and neuronal differentiation (9, 10) . In fact, in vitro experiments demonstrate that neurons are healthier for prolonged times if cultured chronically at oxygen tensions similar to those encountered in vivo (33) . Thus, key hypoxiainducible molecular mechanisms likely contribute to the health of cells in vivo.
Beyond the role of hypoxia in physiologic processes, brain hypoxia also accompanies vascular disease, and HIF-dependent processes are evoked with both acute and chronic brain hypoperfusion (34, 35) . For example, following systemic hypotension and brain hypoperfusion, EPO expression is increased in astrocytes through the actions of HIF-2 (15) . Another pathologic hypoperfusion that may alter the balance of HIF-1 and HIF-2 in the brain is leukoaraiosis, a condition in which white matter damage is prominent, and small-vessel arterial disease likely constitutes the primary cause of Figure 8 . Compared with normoxia to 0.5% O 2 , pretreatment in chronic 2% O 2 prior to severe 0.5% O 2 induces opposite changes of EPO, VEGF, and iNOS levels in astrocytes between 10 mM glucose and in 2 mM glucose. A, B) The abundance of EPO and VEGF secreted into the medium was measured by ELISA. The medium was completely exchanged prior to exposure to severe hypoxia (or normoxia control). A) Compared to normoxia to 0.5% O 2 , EPO protein level in the medium was significantly increased if astrocytes were pretreated with 2% O 2 prior to severe 0.5% O 2 in 10 mM glucose, whereas in 2 mM glucose, EPO abundance was decreased after pretreatment in chronic 2% O 2 . B) Compared with normoxia to 0.5% O 2 , VEGF abundance in the medium was increased by exposure to 2% O 2 and 10 mM glucose but decreased by pretreatment with 2% O 2 in 2 mM glucose. Data are shown as means 6 SEM (n = 6-8 independent experiments; 2-way ANOVA followed by Tukey's multiple comparison test). *P , 0.05 vs. Norm, # P , 0.05 vs. Norm to 0.5%. C, D) Compared with normoxia to 0.5% O 2 , pretreatment in chronic 2% O 2 prior to severe 0.5% O 2 decreased iNOS expression in 10 mM glucose, whereas in 2 mM glucose, iNOS expression was increased in astrocytes. conc, concentration; Norm, normoxia. Data are shown as means 6 SEM (n = 6 independent experiments; 1-way ANOVA followed by Tukey's multiple comparison test). *P , 0.05 vs. Norm, # P , 0.05 vs. Norm to 0.5%. the damage (36) . It is of interest then that HIF-1 is induced in astrocytes of patients with leukoaraiosis and HIF-2 was not induced, suggesting that the normal bias of astrocytes for expressing HIF-2 targets is disturbed in favor of HIF-1 in patients with white matter ischemia (5) . Similarly, following focal ischemia or stroke, EPO is induced in astrocytes. Although astrocyte EPO expression is highly induced within a few hours of exposure of mice to hypoxia (15) , it is not maximal for 7 d after stroke onset (37) , implying that other factors likely impact HIF-2 signaling in vivo during ischemia. Based on our findings, it is tempting to speculate that glucose availability is an important determinant in HIF-2 signaling in vivo. Future work will need to delineate the impact of tipping the balance toward HIF-1 vs. HIF-2 signaling in astrocytes on the viability of neighboring cells during hypoxia and hypoperfusion.
The adaptive and pathologic roles of astrocytes during hypoxia
Astrocytes display both protective and pathologic roles during hypoxia and ischemia (1) (2) (3) . In terms of their protective effects, several molecules secreted by astrocytes are neuroprotective. For example, adenosine, which is derived from ATP secreted by astrocytes, contributes to the neuroprotective effect of hypoxia preconditioning (38) . Secretion of glial-derived neurotropic factor by astrocytes is also neuroprotective (39, 40) . In this study, we focused on the regulation of EPO expression in astrocytes because it is also secreted by astrocytes during hypoxia and has neuroprotectant properties (23, 41, 42) . For example, conditioned medium collected from hypoxic astrocytes protects neurons from injurious stimuli through secretion of EPO (7) . As such, during conditions in which hypoxia is not so severe as to cause cell death but is sufficient to induce EPO from astrocytes (2% O 2 with 10 mM glucose), HIF-2 function in astrocytes is likely to improve tissue viability. In fact, HIF-2 and EPO have been implicated as mediators of neuroprotection with 2% O 2 preconditioning, in accordance with previous studies (23, 24) . It is expected that conditions that reduce astrocyte HIF-2 signaling would compromise neuron viability, as observed in neurons cocultured with HIF-2 2/2 astrocytes in our study. Although most studies have examined the impact of astrocyte function on neuronal viability, clearly astrocyte function also impacts the viability of other cell types, including astrocytes themselves. For example, EPO not only protects neurons but also enhances viability of astrocytes during conditions that mimic ischemia (43, 44) . Moreover, astrocyte-conditioned medium also protects oligodendrocyte precursor cells from injurious stimuli (45) . Thus, understanding the molecular signaling events within astrocytes that influence the ability of astrocytes to support the viability of multiple cell types during hypoxia and ischemia should yield promising targets for future treatment development.
Although the neuroprotective roles of astrocytes during hypoxia are compelling, other evidence suggests that hypoxia signaling in astrocytes is harmful under certain Figure 9 . A summary of the regulation of HIF-1 and HIF-2 target expression as it depends on oxygen and glucose abundance. 1) After astrocytes were cultured in 2% O 2 for 7 d under 10 mM glucose, HIF-2, EPO, and VEGF levels increased, whereas HIF-1 targets (Glut1, HK2, Nip3, and MCT4) were unchanged when compared with astrocytes under normoxia. Next, astrocytes were exposed to 0.5% O 2 under 10 mM glucose for a further 24 h. When compared with astrocytes from normoxia to 0.5% directly, EPO and VEGF protein levels in culture medium were increased, whereas iNOS decreased in astrocytes pretreated with 2% O 2 for 7 d. Under this condition, astrocytes had protective effects of on cocultured neurons. 2) Under 2 mM glucose, after astrocytes were cultured in 2% O 2 for 7 d, HIF-2 EPO levels decreased, whereas VEGF and HIF-1 targets (Glut1, HK2, Nip3, and MCT4) increased when compared with the normoxia group. Then, astrocytes were exposed to 0.5% O 2 under 2 mM glucose for 24 h. When compared with astrocytes from normoxia to 0.5% directly, EPO and VEGF protein levels in culture medium decreased in addition to the transcription of HIF-1 targets (Glut1 and HK2), whereas the iNOS level increased in astrocytes pretreated with 2% O 2 for 7 d. In this condition, the protective effects from astrocytes declined, and thus, apoptosis of cocultured neurons increased.
circumstances. For example, we previously determined that loss of HIF-1 function in astrocytes in cocultures of astrocytes and neurons markedly reduced neuronal death induced by hypoxia (25) . Part of this HIF-1mediated toxicity was mediated through the actions of iNOS in astrocytes (25) . In this study, we also define iNOS as a toxic factor in astrocytes under moderate hypoxia when glucose is limited. Similarly, other investigators demonstrated the toxic effects of astrocytic iNOS during hypoxia-ischemia (46) . Finally, hypoxia and ischemia can combine to augment pathologic functions of astrocytes. In cocultures of neurons and astrocytes, increased IL-1b and hypoxia combine to induce the release of excitotoxic levels of glutamate by astrocytes, resulting in neuronal death (47) . Thus, multiple signaling pathways likely influence astrocytic function, which ultimately define their role of astrocytes as promoting or diminishing tissue viability during hypoxia-ischemia.
Similarities and differences in HIF-1 and HIF-2 signaling in chronic hypoxia
Although multiple studies have studied HIF-1 and HIF-2 responses in acute hypoxia, fewer have examined the effects of chronic hypoxia on HIF-1 and HIF-2 signaling (48) (49) (50) (51) . Several studies agree that HIF-1 protein diminishes in severe chronic hypoxia (usually about 1% O 2 ) (48, 50, 52, 53) . However, to our knowledge, no other study has demonstrated that transactivation of HIF-1 targets increases during exposure to chronic mild to moderate hypoxia (2% O 2 ) when glucose is limited (2 mM glucose). This increase was dependent on HIF-1 function and was not observed when glucose was more prevalent. Typically, glucose concentrations are between 5 and 40 mM in most medium preparations (minimum essential medium, DMEM, and DMEM high glucose), explaining why this pattern of HIF-1 activity would not be typically found in culture experiments. The concentration of glucose normally found in the CSF is between 50 and 80 mg/100 ml, which is equal to 2.7-4.4 mM glucose. Thus, our conditions of limited glucose (2 mM) are near the lower values normally observed in CSF. As such, these lower values may easily be observed in vivo during mild to moderate hypoperfusion, mild hypoglycemia, or meningitis, or in the peri-ischemic tissue following stroke. Thus, this observation has relevance for the regulation of HIF in the brain.
The impact of chronic hypoxia on HIF-2 abundance and function is debated. In 1 study, both HIF-1 and HIF-2 protein abundance diminished over 7 d, whether the cells were exposed to 0.1, 1, or 3% O 2 (53) . Prolyl hydroxylases, which are induced in hypoxia by the HIFs, accounted for the diminished HIF-1 and HIF-2 protein abundance in this study (53) . However, in other work, HIF-1 and HIF-2 were differentially regulated during chronic hypoxia in neuroblastoma cell lines (50, 51) . In 1% O 2 , HIF-2 protein abundance increased over 72 h, whereas HIF-1 protein abundance was diminished (50) . In general, our results agree with this study. When glucose was plentiful, HIF-2-dependent signaling was enhanced in astrocytes but HIF-1 signaling was not enhanced. A difference in our results was that HIF-2 protein abundance did not change in chronic hypoxia although EPO abundance was increased. This suggests that the transactivation of HIF-2 targets can increase in chronic hypoxia independent of changing HIF-2 abundance.
The most distinct difference in our results compared with those of prior studies is the clear decrease in HIF-2 transcript and protein abundance in chronic hypoxia when glucose supply is limited. Multiple studies have demonstrated protein binding partners or posttranslational modifications as the primary means to control the activity or stability of HIF-1 and HIF-2 activity, almost to the exclusion of alterations in transcript abundance (54) . An exception to this rule is that HIF-1 transcript abundance is dependent on NF-kB signaling (55) . Our work demonstrates that HIF-2 activity is similarly modulated by transcript abundance. The fact that ERK phosphorylation is diminished during chronic hypoxia when glucose is diminished suggests a possible signaling pathway altering HIF-2 transcript abundance. Still, future work will be needed to define the mechanisms by which the HIF-2 transcript is controlled by a combination of hypoxia and glucose availability.
In summary, our study helps to reveal the regulating pattern of HIF signaling in astrocytes upon hypoxia and, more importantly, reported that the impacts of astrocytes on neurons are based both on oxygen tension and glucose levels. The profound understanding of the complex response of astrocytes will help in finding new molecular mechanisms by which astrocytes modify neuronal viability during pathology states.
